Parenteral nutrition-induced cholestasis disrupts bile acid-mediated activation of intestinal FXR-FGF19 signaling, and we showed that treatment with enteral chenodeoxycholic acid (CDCA) restored FGF19 secretion and reduced serum cholestasis in neonatal pigs (15). This evidence concerns the gene FGF19 and cholestasis.